CD35 Polyclonal Antibody, APC Conjugated
Product Specifications
Background
Mediates cellular binding of particles and immune complexes that have activated complement.
Synonyms
KN; C3BR; C4BR; CD35; Complement receptor type 1; C3b/C4b receptor; CR1
Gene ID
1378
Swiss Prot
P17927
Cellular Locus
Cell membrane
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Immunogen
1301-1400/2039
Target
CD35
Clonality
Polyclonal
Isotype
IgG
Conjugation
APC
Source
KLH conjugated synthetic peptide derived from human CR1/CD35
Applications
IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
650nm/660nm
Concentration
1µg/µl
Dilution
IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Specificity
May recognize Complement component receptor 1-like protein in certain tissues, which is expressed in fetal liver and to a lesser extent in fetal spleen and thymus.
Gene ID URL
1378
More Discoveries
Explore Other Products
Browse additional items from our catalog
246248-ML405 100 µL
FOS (v-fos FBJ murine Osteosarcoma Viral Oncogene Homolog, AP-1, C-FOS) (MaxLight 405) discontinued
Sign In for Pricing
View Details ![7-Oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine-4-carboxylic acid](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
OR350524 1 Each
7-Oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine-4-carboxylic acid
Sign In for Pricing
View Details